Tag: NASDAQ:CEMP

Finance

Top Wall Street Stories: Newmont Mining Corporation (NYSE:NEM), Frontier Communications Corporation (NASDAQ:FTR), Cempra, Inc. (NASDAQ:CEMP), King Digital Entertainment (NYSE:KING), Baytex Energy (NYSE:BTE)

Newmont Mining Corporation (NYSE:NEM) has prepaid $100 million toward a 5-year $575 million unsecured amortizing term loan received in Mar 2014. The term loan was utilized to repay $575 million of convertible debt which matured in Jul 2014. Newmont Mining Corporation (NYSE:NEM) belongs to Basic Materials sector. Its net profit margin is -7.70% and weekly performance is 2.20%. On last trading day company shares ended … Continue reading Top Wall Street Stories: Newmont Mining Corporation (NYSE:NEM), Frontier Communications Corporation (NASDAQ:FTR), Cempra, Inc. (NASDAQ:CEMP), King Digital Entertainment (NYSE:KING), Baytex Energy (NYSE:BTE)

Jason Knox
Finance

Trending Tickers: Cubist Pharmaceuticals (NASDAQ:CBST), Cempra (NASDAQ:CEMP), Meridian Bancorp (NASDAQ:EBSB), Point.360 (NASDAQ:PTSX), Taminco (NYSE:TAM)

Cubist Pharmaceuticals Inc (CBST) announced yesterday, it is recalling 101 production lots of its antibiotic Cubicin (daptomycin injection) amid fear of glass particles being present in the drug. Cubicin, which is intravenously administered, is used to treat blood and skin infections. Cubist Pharmaceuticals Inc. (NASDAQ:CBST) belongs to Healthcare sector. Its net profit margin is 0.70% and weekly performance is 0.58%. On last trading day company … Continue reading Trending Tickers: Cubist Pharmaceuticals (NASDAQ:CBST), Cempra (NASDAQ:CEMP), Meridian Bancorp (NASDAQ:EBSB), Point.360 (NASDAQ:PTSX), Taminco (NYSE:TAM)

John Meady
Finance

Biotech Gainers: Ignyta Inc (NASDAQ:RXDX), Onconova Therapeutics Inc (NASDAQ:ONTX), Cempra Inc (NASDAQ:CEMP), ANI Pharmaceuticals Inc (NASDAQ:ANIP)

Ignyta Inc (NASDAQ:RXDX) released its earnings data. The company reported ($0.28) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.37) by $0.09. Finally, analysts at Ladenburg Thalmann initiated coverage on shares of company in a research note on Monday, March 24th. They set a “buy” rating and a $20.00 price target on the stock. Ignyta Inc (NASDAQ:RXDX) stock performance was 13.12% … Continue reading Biotech Gainers: Ignyta Inc (NASDAQ:RXDX), Onconova Therapeutics Inc (NASDAQ:ONTX), Cempra Inc (NASDAQ:CEMP), ANI Pharmaceuticals Inc (NASDAQ:ANIP)

Chris Lewis
BBRY NASDAQ BBRY Blackberry
BioTech

Hot Stocks: BlackBerry Ltd (NASDAQ:BBRY), Comtech Telecomm. Corp. (NASDAQ:CMTL), Cempra Inc (NASDAQ:CEMP), Aaron’s, Inc. (NYSE:AAN)

BlackBerry (NASDAQ:BBRY) was upgraded by investment analysts at Oppenheimer from an “underperform” rating to a “market perform” rating in a note issued to investors on Tuesday, Analyst RN reports. BlackBerry Ltd (NASDAQ:BBRY) stock performance was -3.28% in last session and finished the day at $ 7.67. Traded volume was 150.00 million shares in the last session and the average volume of the stock remained 16.18 … Continue reading Hot Stocks: BlackBerry Ltd (NASDAQ:BBRY), Comtech Telecomm. Corp. (NASDAQ:CMTL), Cempra Inc (NASDAQ:CEMP), Aaron’s, Inc. (NYSE:AAN)

John Bellich
BioTech

Unusual Volume Biotech Stocks: Compugen Ltd (NASDAQ:CGEN), Sinovac Biotech (NASDAQ:SVA), Enzymotec (NASDAQ:ENZY), Cempra (NASDAQ:CEMP)

Over the past three years, using its in-silico discovery platform for predictive drug discovery (i.e. computer models and algorithms), Compugen Ltd. (USA) (NASDAQ:CGEN) has developed a hugely compelling drug Pipeline across several clinical areas. Compugen Ltd. (USA) (NASDAQ:CGEN) stock performance was -20.14% in last session and finished the day at $11.34. Traded volume was 22,668.00 shares in the last session and the average volume of … Continue reading Unusual Volume Biotech Stocks: Compugen Ltd (NASDAQ:CGEN), Sinovac Biotech (NASDAQ:SVA), Enzymotec (NASDAQ:ENZY), Cempra (NASDAQ:CEMP)

Richard Atkins
Finance

Top Stocks: Cempra, Inc. (NASDAQ:CEMP), Applied Materials, Inc. (NASDAQ:AMAT), Xcel Energy Inc. (NYSE:XEL), Culp, Inc. (NYSE:CFI), Xilinx Inc. (NASDAQ:XLNX)

Cempra Inc. (NASDAQ:CEMP) announced positive topline results from a global, pivotal Phase 3 clinical trial of solithromycin oral capsules or Solitaire-Oral in the treatment of patients with community acquired bacterial pneumonia or CABP. Cempra, Inc. (NASDAQ:CEMP) belongs to Healthcare sector. Its weekly performance is 10.79%. On last trading day company shares ended up $22.89. Cempra, Inc. (NASDAQ:CEMP) distance from 50-day simple moving average (SMA50) is … Continue reading Top Stocks: Cempra, Inc. (NASDAQ:CEMP), Applied Materials, Inc. (NASDAQ:AMAT), Xcel Energy Inc. (NYSE:XEL), Culp, Inc. (NYSE:CFI), Xilinx Inc. (NASDAQ:XLNX)

Harvey Dyer